Healthcare Roundup – European regulators on board with Mylan/Upjohn tie-up, BioCryst feels Gilead’s remdesivir pain Life Science
Healthcare Roundup – FDA OKs Immunomedics antibody-drug conjugate for breast cancer, Pfizer and BioNTech on go with COVID-19 vaccine study Life Science
Healthcare Roundup – Liberty Health Sciences updates business amid COVID-19, Atyr Pharma on go with study of lead drug in COVID-19 Life Science
Healthcare Roundup – Another U.S. study points to far higher rate of COVID infection, Money flow spikes in COVID-19 vaccine players amid rush for early data Life Science
Transcenta Received IND Clearance from FDA for Initiating Clinical Trials for its Novel Humanized Claudin 18.2 Monoclonal Antibody TST001 Life Science
Fosun Pharma Receives FDA Emergency Use Authorization (EUA) For Its COVID-19 RT-PCR Detection Kit Life Science
Healthcare Roundup – U.S. COVID-19 testing capacity still constrained, Sanofi can produce up to 600M doses of COVID-19 vaccine Life Science
Healthcare Roundup – Gilead up 6% after hours on remdesivir buzz in COVID-19, New York, East Coast states extend lockdown to May 15 Life Science
Pandemic to bring Asia’s 2020 growth to halt for 1st time in 60 years – IMF Consumer Goods, Energy, Financial Service, Life Science
Healthcare Roundup – Baxter plans to hire up to 2K new employees, Moderna teams up with Ginkgo Bioworks Life Science
Harbour BioMed Receives Chinese Regulatory Approval of IND Application to Begin Seamless Phase 2/3 Clinical Trial of HBM9161 in Immune Thrombocytopenia Life Science
